Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication?
Zc. Guo et al., Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication?, AM J EPIDEM, 153(3), 2001, pp. 225-231
Citations number
51
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
The authors examined the impact of the apolipoprotein E (APOE)*epsilon4 all
ele on Alzheimer's disease incidence in relation to use of antihypertensive
medication. A population-based (Kungsholmen Project) cohort of 985 nondeme
nted Swedish subjects aged greater than or equal to 75 years was followed f
or an average of 3 years (1990-1992); 164 dementia (122 Alzheimer's disease
) cases were identified. Compared with *epsilon3/*epsilon3, the APOE*epsilo
n4 allele increased the risk of developing dementia (relative risk (RR) = 1
.5, 95% confidence interval (CI):1.1, 2.1) and Alzheimer's disease (RR = 1.
7, 95% CI: 1.2, 2.5). Subjects using antihypertensive medication at baselin
e (n = 432, 80% used diuretics) had a decreased risk of dementia (RR = 0.6,
95% Cl: 0.5, 0.9) and Alzheimer's disease (RR = 0.5, 95% CI: 0.3, 0.8) aft
er adjustment for several variables, including APOE. The effect of antihype
rtensive medication use was more pronounced among *epsilon4 carriers. For t
hose not using antihypertensive medication, the relative risks of dementia
and Alzheimer's disease for carriers were 2.2 (95% CI: 1.4, 3.4) and 2.3 (9
5% CI: 1.4, 3.7), respectively. The corresponding relative risks for those
using antihypertensive medication were 0.9 (95% CI: 0.5, 1.6) and 1.1 (95%
CI: 0.6, 2.2). The APOE*epsilon4 allele is an important predictor of dement
ia and Alzheimer's disease incidence. Further studies are needed to clarify
whether use of antihypertensive medication, especially diuretics, modifies
the effect of the allele.